Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
DON'T BUY

Novelion(NVLN.TO)

Jun 03, 2003
Has a lot of work to do to break out and get moving again.
Photo of Richard StoneRichard StoneUnlock Rating
$17.68

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

May 22, 2003
Some good products. Dropped recently on a drug (cancer) problem, but a minimal problem.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$15.79

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

May 13, 2003
Very volatile. Sector is doing well but there are better companies.
Photo of David BurrowsDavid BurrowsUnlock Rating
$16.18

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Mar 31, 2003
Good results on their Visodine. The future is bright.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$15.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Mar 05, 2003
Its a real company that has done really well. The stock price has not reflected it as yet.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$12.45

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Feb 03, 2003
Has trouble expanding its product use. Speculative.
Photo of Laura WallaceLaura WallaceUnlock Rating
$12.28

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jan 31, 2003
A one product company.
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$12.30

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jan 30, 2003
Need to get settled in the US/European market places. Stock will be quiet over the next while.
Photo of Richard StoneRichard StoneUnlock Rating
$11.82

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jan 21, 2003
Visudine sales numbers are coming out soon and expect they will be good. Their drug pipeline is expanding. Cheap.
Photo of John ZechnerJohn ZechnerUnlock Rating
$12.44

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jan 14, 2003
Has had regulatory problems in Th US. Nervous on pharmaceuticals at this time.
Photo of David BaskinDavid BaskinUnlock Rating
$13.12

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jan 10, 2003
Sales are poorer than expected.Trading at 20 X earnings. Has a history of missing their numbers.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$12.80

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jan 06, 2003
Prefers others. A lot of competition.
Photo of Michael SprungMichael SprungUnlock Rating
$13.45

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Novelion(NVLN.TO)

Dec 23, 2002
A one trick pony. Same competition.
Photo of Ted MacklinTed MacklinUnlock Rating
$13.08

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Dec 06, 2002
Should be able to expand into new drugs. Growth in their Visodine should be good.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$14.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Oct 18, 2002
Has an interesting new drug. Got FDA approval for their eye drug. Price is down.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$12.70

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 76 to 90 of 190 entries
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica